Do you want to be a true pioneer? Do you get excited by the challenge of overcoming the bioavailability issues of poorly water-soluble small molecules? Do you enjoy working in a dynamic environment where teamwork is at the top of the agenda? If yes, you could be our new scientist in the Emerging Products and Outsourcing department in Måløv. Apply today and join us in developing the next generation of innovative oral products in Novo Nordisk. The position The Novo Nordisk pipeline is growing and with it new small molecule drug candidates that have low solubility (BCS class II and class IV). We are therefore looking for a colleague with passion for the development of solid oral dosage forms with a focus on bioavailability enhancing (enabling) technologies, to bring these candidates forward in development. In your role, you will collaborate with our contract development and manufacturing organisations (CDMOs) to develop formulations and manufacturing processes for new oral drug products. As process and production responsible your main task will be to work with our CDMOs on development studies and clinical productions, ensuring that we develop and deliver product, for all stages of clinical development. Enabling technologies will be applied as necessary based on the need within each specific project. With your experience from the pharmaceutical industry, you represent the department in multi-disciplinary project groups. You work closely with experts from a wide range of areas and CDMOs. In addition, you will also plan project activities in close collaboration with the project- and line management. Qualifications To succeed in this role, you have: • A Master’s degree within Life Sciences (e.g., engineering, pharmaceutical sciences) or similar • Experience from the pharmaceutical industry or academia • Experience with development of small molecule pharmaceuticals • Experience with formulation and process optimisation of solid dosage forms • Experience with enabling technologies for dissolution rate enhancement • Fluent in spoken and written English • Experience with outsourcing and GMP manufacture at CDMO is an advantage but not a requirement • Similarly, experience with solid state characterization of small molecules (API/DP) is an advantage As an individual you enjoy working in a dynamic environment where teamwork is at the top of the agenda. You are a self-starter taking responsibility for your tasks. You set realistic deadlines and reach them together with the rest of the team. We expect you to have excellent collaboration and communication skills with an eye for stakeholder management. As a senior you have the ability and skills to set direction scientifically and be a role model for your junior colleagues. About the department The department “Emerging Technologies and Outsourcing” is part of the Oral Product Development area in Novo Nordisk. The main task of the department is to develop manufacturing processes for products in clinical development, bringing best-in-class treatments to the market. For new oral drug products developed in house, the manufacture takes place in our pilot plants, while products developed at CDMOs are manufactured by the CDMO. Emerging Technologies and Outsourcing consists of 30+ colleagues organised in 2 teams, one responsible for developing and manufacturing oral drug products in-house and one for outsourced products. The team, Outsourced Product Development, consists of 7 dedicated and enthusiastic colleagues. In our team, the ambition is to develop oral drug product formulations and processes in collaboration with CDMOs. The team covers process development from early clinical phases until launch. Working at Novo Nordisk Novo Nordisk is its people. We know that life is anything but linear and balancing what is important at different stages of our careers is never easy. That’s why we make room for diverse life situations, always putting people first. We value our employees for the unique skills they bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk is working toward something bigger than ourselves, and it’s a collective effort. Novo Nordisk relies on the joint potential and collaboration of its more than 40,000 employees. Together, we go further. Together, we’re life changing. Contact For further information please contact Senior Formulation Scientist Anne Zimmermann at +45 3077 6848 or Associate Manager Joakim Ro-Poulsen at +45 3077 6991. Deadline 1 October, 2023. Please note that applications are screened on an ongoing basis, so you are encouraged to apply as soon as possible. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.